Patent: 5,980,884
✉ Email this page to a colleague
Summary for Patent: 5,980,884
| Title: | Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon |
| Abstract: | Methods for the retreatment, using a therapeutically effective amount of interferon consensus, of patients with HCV who exhibit serum ALT values above the upper limit of normal after previous treatment with interferon. |
| Inventor(s): | Blatt; Larry (Boulder, CO), Klein; Michael (Thousand Oaks, CA) |
| Assignee: | Amgen, Inc. (Thousand Oaks, CA) |
| Application Number: | 08/595,440 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,980,884
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Kadmon Pharmaceuticals Llc | INFERGEN | interferon alfacon-1 | Injection | 103663 | 10/06/1997 | ⤷ Try a Trial | 2039-03-29 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,980,884
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 1531897 | ⤷ Try a Trial |
| Brazil | 9700829 | ⤷ Try a Trial |
| Canada | 2244696 | ⤷ Try a Trial |
| China | 1217660 | ⤷ Try a Trial |
| Czech Republic | 231998 | ⤷ Try a Trial |
| Eurasian Patent Organization | 199800674 | ⤷ Try a Trial |
| European Patent Office | 0879059 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
